Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689548-23-000159
Filing Date
2023-11-07
Accepted
2023-11-07 07:37:36
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prax-20230930.htm   iXBRL 10-Q 849193
2 EX-31.1 exhibit31120230930.htm EX-31.1 13046
3 EX-31.2 exhibit31220230930.htm EX-31.2 14365
4 EX-32.1 exhibit32120230930.htm EX-32.1 13370
  Complete submission text file 0001689548-23-000159.txt   4384223

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20230930.xsd EX-101.SCH 30696
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prax-20230930_cal.xml EX-101.CAL 46961
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prax-20230930_def.xml EX-101.DEF 155516
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20230930_lab.xml EX-101.LAB 430386
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20230930_pre.xml EX-101.PRE 276681
54 EXTRACTED XBRL INSTANCE DOCUMENT prax-20230930_htm.xml XML 448784
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39620 | Film No.: 231381600
SIC: 2834 Pharmaceutical Preparations